Company intelligence / Profile preview
Wuhan Createrna Science and Technology Co., Ltd.
Wuhan, Hubei, Chinacreaterna.com ↗
- Ownership
- Private
- Employees
- ~240
- Development stage
- Phase 1
01
Overview
The company has multiple programs in clinical trials, with QR-12000 and MY-008211A in Phase 3 for Essential Hypertension and Paroxysmal Hemoglobinuria respectively. Several other programs are in Phase 2 and Phase 1 clinical trials.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularNephrologyImmunologyDermatologyHematology
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
03
Partnerships
300+ partners (specific names not provided)
Beyond the preview
Go deeper on Wuhan Createrna Science and Technology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan Createrna Science and Technology Co., Ltd..